Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma
Academic Article
Overview
MeSH Major
Antineoplastic Combined Chemotherapy Protocols
Eye Neoplasms
Melanoma
Mouth Neoplasms
Skin Neoplasms
abstract
The combination of temozolomide plus pegylated IFN-alpha-2b had antitumor activity and was well tolerated in patients with metastatic melanoma. Therefore, further study is warranted.
